IBRX

NASDAQ · Biotechnology

Immunitybio Inc

Mid-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$7.32

+0.10 (+1.39%)

Earnings History

Date	Quarter	EPS Est	EPS Actual	Surprise	Surprise %	Result
May 11, 2026	Q2 FY2026	$-0.07	—	—	—	—
Mar 3, 2026	Q1 FY2026	$-0.10	—	—	—	—

Related Earnings News

ImmunityBio's Anktiva Expansion Faces FDA Scrutiny with 2027 Decision Date

Regulation · May 20

ImmunityBio Secures Exclusive US Rights to Japan BCG Strain for Bladder Cancer

Markets · May 16

ImmunityBio Plunges 21% on FDA Warning Over Anktiva Marketing

Regulation · Mar 25

ImmunityBio Surges on NK-Cell Manufacturing Milestone, Anktiva Expansion Progress

Technology · Mar 13